Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Dan, Jennifer M., Mateus, Jose, Kato, Yu, Hastie, Kathryn M., Yu, Esther Dawen, Faliti, Caterina E., Grifoni, Alba, Ramirez, Sydney I. +13 more·2021·Science

DOI 10.1126/science.abf4063

Cited by (1,011)

Items 301–400 of 1,011

Fear of COVID-19 predicts vaccination willingness 14 months later
Gaëtan Mertens, Paul Lodder, Tom Smeets, Stefanie Duijndam · 2022 · Journal of Anxiety Disorders
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
Maurice Steenhuis, Gerard J. van Mierlo, Ninotska I. L. Derksen, Pleuni Ooijevaar‐de Heer, Simone Kruithof, Floris C. Loeff, Lea C. Berkhout, Federica Linty, Chantal B. E. M. Reusken, Johan H J Reimerink et al. · 2021 · Clinical & Translational Immunology
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal · 2023 · Frontiers in Immunology
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant
Rofhiwa Nesamari, Millicent A. Omondi, Richard Baguma, Maxine A. Höft, Amkele Ngomti, Anathi A. Nkayi, Asiphe S. Besethi, Siyabulela F. J. Magugu, Paballo Mosala, Avril Walters et al. · 2024 · Cell Host & Microbe
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study
Antonio Leidi, Flora Koegler, Roxane Dumont, Richard Dubos, María-Eugenia Zaballa, Giovanni Piumatti, Matteo Coen, Amandine Berner, Pauline Darbellay Farhoumand, Pauline Vetter et al. · 2021 · Clinical Infectious Diseases
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
Kathleen M. Wragg, Wen Shi Lee, Marios Koutsakos, Hyon‐Xhi Tan, Thakshila H. Amarasena, Arnold Reynaldi, Grace Gare, Penny Konstandopoulos, Kirsty R. Field, Robyn Esterbauer et al. · 2022 · Nature Immunology
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection
Costanza Di Chiara, Anna Cantarutti, Paola Costenaro, Daniele Donà, Francesco Bonfante, Chiara Cosma, Martina Ferrarese, Sandra Cozzani, Maria Raffaella Petrara, Francesco Carmona et al. · 2022 · JAMA Network Open
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery
Maddalena Peghin, Maria De Martino, Martina Fabris, Alvisa Palese, Erica Visintini, Elena Graziano, Valentina Gerussi, Giulia Bontempo, Federica D’Aurizio, Alessia Biasotto et al. · 2021 · Journal of Clinical Microbiology
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
Sebastian Havervall, Henry Ng, August Jernbom Falk, Nina Greilert‐Norin, Anna Månberg, Ulrika Wimmercranz Marking, Ida Laurén, Lena Gabrielsson, Ann‐Christin Salomonsson, Katherina Aguilera et al. · 2021 · Journal of Internal Medicine
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Francesco Annunziato, Lorenzo Cosmi · 2021 · Seminars in Immunology
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
Stéphane Pillet, Prabhu S. Arunachalam, Guadalupe Andreani, Nadia Golden, Jane A. Fontenot, Pyone P. Aye, Katharina Röltgen, Gabrielle Lehmicke, Philipe Gobeil, Charlotte Dubé et al. · 2022 · Cellular and Molecular Immunology
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
Lotus L. van den Hoogen, Gaby P. Smits, Cheyenne C. E. van Hagen, Denise Wong, Eric R. A. Vos, Michiel van Boven, Hester E. de Melker, Jeffrey van Vliet, Marjan Kuijer, Linde Woudstra et al. · 2022 · Vaccine
The role of immune activation and antigen persistence in acute and long COVID
Skye Opsteen, Jacob K. Files, Tim Fram, Nathan B. Erdmann · 2023 · Journal of Investigative Medicine
Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study
Nathanaël Hozé, Juliette Paireau, Nathanaël Lapidus, Cécile Tran Kiem, Henrik Salje, Gianluca Severi, Mathilde Touvier, Marie Zins, Xavier Nicolas de Lamballerie, Daniel Lévy-Bruhl et al. · 2021 · The Lancet Public Health
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
Stéphane Pelleau, Tom Woudenberg, Jason Rosado, Françoise Donnadieu, Laura García, Thomas Obadia, Soazic Gardais, Yasmine Elgharbawy, Aurélie Velay, Maria Gonzalez et al. · 2021 · The Journal of Infectious Diseases
Heterogeneity of human anti-viral immunity shaped by virus, tissue, age, and sex
Maya M.L. Poon, Eve Byington, Wenzhao Meng, Masaru Kubota, Rei Matsumoto, Alba Grifoni, Daniela Weiskopf, Pranay Dogra, Nora Lam, Peter Anthony Szabo et al. · 2021 · Cell Reports
Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
Matthew K. Siggins, Ryan S. Thwaites, Peter Openshaw · 2021 · Trends in Microbiology
SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon
Kenechukwu Obumneme Samuel Nwosu, Joseph Fokam, Franck Wanda, Lucien Mama, Erol Orel, Nicolas Ray, Jeanine Meke, Armel Tassegning, Désiré Takou, Eric Mimbe et al. · 2021 · Nature Communications
Supplying the trip to antibody production—nutrients, signaling, and the programming of cellular metabolism in the mature B lineage
Mark Robin Boothby, Shawna K. Brookens, Ariel L. Raybuck, Sung Hoon Cho · 2021 · Cellular and Molecular Immunology
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, María Ruiz‐Ruigómez, Alberto Utrero‐Rico, Antonio Lalueza, Guillermo Maestro de la Calle, Pilar Delgado, Luis Pérez Ordoño, Eva Muro, Juan José Vila et al. · 2021 · PLoS Pathogens
Oral Pathology in COVID-19 and SARS-CoV-2 Infection—Molecular Aspects
Agnieszka Droździk, Marek Droździk · 2022 · International Journal of Molecular Sciences
Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
Yongjun Sui, Yonas Bekele, Jay A. Berzofsky · 2021 · Pathogens
COVID-19: Immunology, Immunopathogenesis and Potential Therapies
Asha Bhardwaj, Leena Sapra, Chaman Saini, Zaffar Azam, Pradyumna Kumar Mishra, Bhupendra Verma, Gyan C. Mishra, Rupesh Kumar Srivastava · 2021 · International Reviews of Immunology
Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
Niko Kohmer, Cornelia Rühl, Sandra Ciesek, Holger Felix Rabenau · 2021 · Journal of Clinical Medicine
Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers
Louise Benning, Maximilian Töllner, Åsa S. Hidmark, Matthias Schaier, Christian Nußhag, Florian Kälble, Paula Reichel, Mirabel Buylaert, Julia Grenz, Gerald D. Ponath et al. · 2021 · Vaccines
T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance C. W. Turtle, Alex G Richter, Christopher James Arthur Duncan, Susanna Jane Dunachie, Paul Klenerman, Rebecca Payne · 2023 · BMJ Medicine
mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, Divij Mathew, Wenzhao Meng, Aaron M. Rosenfeld, Kendall A. Lundgreen, Arnold Reynaldi, David S. Khoury, Ajinkya Pattekar et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection
Valeria De Giorgi, Kamille A. West, Amanda N. Henning, Leonard N. Chen, Michael R. Holbrook, Robin Gross, Janie Y. Liang, Elena N. Postnikova, Joni L. Trenbeath, Sarah Pogue et al. · 2021 · The Journal of Infectious Diseases
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
Delia Goletti, Linda Petrone, Davide Manissero, Antonio Bertoletti, Sonia N. Rao, Nduku Ndunda, Alessandro Sette, Vladyslav Nikolayevskyy · 2021 · Clinical Microbiology and Infection
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses
Jared E. Feldman, Julia Bals, Clara G. Altomare, Kerri St. Denis, Evan Christopher Lam, Blake Marie Hauser, Larance Ronsard, Maya Sangesland, Thalia Bracamonte Moreno, Vintus Okonkwo et al. · 2021 · Science Immunology
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study
Priscilla Kim, Steven Mark Gordon, Megan M. Sheehan, Michael B. Rothberg · 2021 · Clinical Infectious Diseases
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines
Violette Mouro, Alain Fischer · 2022 · Mucosal Immunology
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern
Rajesh Vikkurthi, Asgar Ansari, Anupama Ramakanth Pai, Someshwar Nath Jha, Shilpa Sachan, Suvechchha Pandit, Bhushan Nikam, Anurag Kalia, Bimal Prasad Jit, Hilal Ahmad Parray et al. · 2022 · Nature Microbiology
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
Chen Sabrina Tan, Ai-ris Yonekura Collier, Jingyou Yu, Jinyan Liu, Abishek Chandrashekar, Katherine McMahan, Catherine Jacob-Dolan, Xuan He, Vicky Roy, Blake Marie Hauser et al. · 2022 · JAMA Network Open
Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients
Qihong Yan, Pingchao Li, Xianmiao Ye, Xiaohan Huang, 莫晓能, Qian Wang, Yudi ZHANG, Luo Kun, Zhaoming Chen, Jia Luo et al. · 2021 · The Journal of Immunology
Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
Carlota Dobaño, Anna Ramírez‐Morros, Selena Alonso, Josep Vidal‐Alaball, Gemma Ruiz‐Olalla, Marta Vidal, Rocío Rubio, Emma Cascant, Daniel Parras, Natalia Rodrigo Melero et al. · 2021 · BMC Medicine
Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine
Chiara Agrati, Concetta Castilletti, Delia Goletti, Silvia Meschi, Alessandra Sacchi, Giulia Matusali, Veronica Bordoni, Linda Petrone, Daniele Lapa, Stefania Notari et al. · 2021 · Microorganisms
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, Mary Luder, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, Ramesh Balusu, Shaun DeJarnette, Clint L. Divine et al. · 2021 · Transplantation and Cellular Therapy
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
I. Trougakos, E. Terpos, Christina Zirou, A. Sklirou, F. Apostolakou, S. Gumeni, Ioanna Charitaki, Eleni-Dimitra Papanagnou, T. Bagratuni, C. Liacos et al. · 2021 · BMC Medicine
COVID-19 vaccines: Current evidence and considerations
Alireza Tavilani, Ebrahim Abbasi Oshaghi, Farhad Kian Ara, Ali Darini, Zahra Asefy · 2021 · Metabolism Open
SARS-CoV-2 epitope–specific CD4 + memory T cell responses across COVID-19 disease severity and antibody durability
Ryan W. Nelson, Yuezhou Chen, Olivia L. Venezia, Richard M. Majerus, Daniel Sanghoon Shin, MGH COVID-19 Collection & Processing Team, Mary N Carrington, Xu G. Yu, Duane R. Wesemann, James J. Moon et al. · 2022 · Science Immunology
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine
Tomohiro Takano, Miwa Morikawa, Yu Adachi, Kiyomi Kabasawa, Nicolas Sax, Saya Moriyama, Lin Sun, Masanori Isogawa, Ayae Nishiyama, Taishi Onodera et al. · 2022 · Cell Reports Medicine
Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens
Vijayashree Mysore, Xavier Culleré, Matthew Lee Settles, Xinge Ji, Michael W. Kattan, Michaël Desjardins, Blythe P Durbin-Johnson, Tal Gilboa, Lindsey Robert Baden, David R. Walt et al. · 2021 · Med
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study
Ole Schmeltz Søgaard, Joanne Reekie, Işık Somuncu Johansen, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Kasper Karmark Iversen, Kamille Fogh, Jacob Bodilsen et al. · 2022 · Clinical Microbiology and Infection
Immunogenicity and Safety of Standard and Third‐Dose SARS – CoV ‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Trung The Tran, Joseph Sexton, Sella Aarrestad Provan, Siri Mjaaland, David John Warren, Tore Kristian Kvien, Gunnveig Grødeland et al. · 2022 · Arthritis & Rheumatology
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers
Andrea Padoan, Francesco Bonfante, Chiara Cosma, Costanza Di Chiara, Laura Sciacovelli, Matteo Pagliari, Alessio Bortolami, Paola Costenaro, Giulia Musso, Daniela Basso et al. · 2021 · Clinical Chemistry and Laboratory Medicine (CCLM)
SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19
Vivian Glück, Sonja Grobecker, Leonid Tydykov, Bernd Salzberger, Thomas Glück, Tanja Weidlich, Manuela Bertok, Christine Gottwald, Jürgen J. Wenzel, André Gessner et al. · 2021 · Infection
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Chang Kyung Kang, Minji Kim, Soojin Lee, Gwanghun Kim, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Chang‐Han Lee, Ik Soo Kim, Keehoon Jung et al. · 2021 · The Journal of Infectious Diseases
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
Alessandra Aiello, Saeid Najafi Fard, Elisa Petruccioli, Linda Petrone, Valentina Vanini, Chiara Farroni, Gilda Cuzzi, Assunta Navarra, Gina Gualano, Silvia Mosti et al. · 2021 · International Journal of Infectious Diseases
COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding
Lydia L. Shook, Parisa Nicole Fallah, Jason N. Silberman, Andrea G. Edlow · 2021 · Frontiers in Cellular and Infection Microbiology
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey
Michael D. Swartz, Stacia M. DeSantis, Ashraf S. Yaseen, Frances A. Brito, Melissa A. Valerio-Shewmaker, Sarah Elizabeth Messiah, Luis León‐Novelo, Harold Willis Kohl, Cesar Leonardo Pinzon-Gomez, Tianyao Hao et al. · 2022 · The Journal of Infectious Diseases
Resolving SARS-CoV-2 CD4+ T cell specificity via reverse epitope discovery
Mikhail V. Pogorelyy, Elisa Rosati, Anastasia A. Minervina, Robert C. Mettelman, Alexander Scheffold, André Franke, Petra Bächer, Paul Glyndwr Thomas · 2022 · Cell Reports Medicine
SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
Jernej Pušnik, Werner Otoniel Monzon‐Posadas, Jasmin Zorn, Kathrin Peters, Maximilian Baum, Hannah Proksch, Celina Beta Schlüter, Galit Alter, Tanja Menting, Hendrik Streeck · 2023 · Nature Communications
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, Camille Esneau, Mariana Ruiz Silva, Timothy Ison, Christina Fichter, Joseph A. Lopez, Deborah Chandra, Zin Naing et al. · 2023 · EBioMedicine
Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2
Yves Zurbuchen, Jan Michler, Patrick Taeschler, Sarah Adamo, Carlo Cervia, Miro E. Raeber, İlhan E. Acar, Jakob Nilsson, Klaus Warnatz, Michael Soyka et al. · 2023 · Nature Immunology
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection
Julien Favresse, Christine Eucher, Marc Elsen, Constant Gillot, Sandrine Van Eeckhoudt, Jean‐Michel Dogné, Jonathan Douxfils · 2021 · Microorganisms
Correlates of Vaccine-Induced Protection against SARS-CoV-2
Till Koch, Sibylle C. Mellinghoff, Parichehr Shamsrizi, Marylyn M. Addo, Christine Dahlke · 2021 · Vaccines
Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand
Alana L. Whitcombe, Reuben McGregor, Alyson Craigie, Alex James, Richard Charlewood, Natalie Lorenz, James M. J. J. Dickson, Campbell R. Sheen, Barbara Koch, Shivani Fox‐Lewis et al. · 2021 · Clinical & Translational Immunology
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants
Yuxin Chen, Lin Chen, Shengxia Yin, Yue Tao, Liguo Zhu, Xin Tong, Minxin Mao, Ming Li, Yawen Wan, Jun Ni et al. · 2022 · Emerging Microbes & Infections
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors
Alison Tarke, Marina Potestà, Stefania Varchetta, Daniela Fenoglio, Marco Iannetta, Loredana Sarmati, Dalila Mele, Chiara Dentone, Matteo Bassetti, Carla Montesano et al. · 2022 · International Journal of Molecular Sciences
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Guo Qian, Harish Narasimhan, Jie Sun · 2022 · Journal of Medical Virology
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
Chapin S. Korosec, Suzan Farhang‐Sardroodi, David W. Dick, Sameneh Gholami, Mohammad Sajjad Ghaemi, Iain R. Moyles, Morgan Craig, Hsu Kiang Ooi, Jane Marie Heffernan · 2022 · Scientific Reports
Role of T cells in severe COVID-19 disease, protection, and long term immunity
Julia Maret Hermens, Can Keşmir · 2023 · Immunogenetics
Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model
Ami R. Patel, Jewell N. Walters, Emma L. Reuschel, Katherine Schultheis, Elizabeth M. Parzych, Ebony Nicole Gary, Igor Maricic, Mansi Purwar, Zeena Eblimit, Susanne N. Walker et al. · 2021 · Cell Reports Medicine
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
Perez-Saez, Javier, Zaballa, María-Eugenia, Yerly, Sabine, Andrey, Diego O., Meyer, Benjamin, Eckerle, Isabella, Balavoine, Jean-François, Chappuis, François, Pittet, Didier, Trono, Didier et al. · 2021 · Clinical Microbiology and Infection
COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology
Jin Kyun Park, Eun Bong Lee, Kichul Shin, Yoon‐Kyoung Sung, Tae‐Hwan Kim, Seong‐Ryul Kwon, Myeung Su Lee, Seung‐Jae Hong, Byoong Yong Choi, Shin‐Seok Lee et al. · 2021 · Journal of Korean Medical Science
One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms
Andreas Rank, Athanasia Tzortzini, Elisabeth Kling, Christoph Schmid, Rainer Claus, Eva Loell, Roswitha Burger, Christoph Römmele, Christine Dhillon, Katharina Müller et al. · 2021 · Journal of Clinical Medicine
Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
Kunsulu D. Zakarya, Кутумбетов Леспек Бекболатович, Mukhit B. Orynbayev, Yergali O. Abduraimov, Kulyaisan T. Sultankulova, Markhabat Kassenov, Gulbanu Sarsenbayeva, И. Р. Кулмагамбетов, Timur I. Davlyatshin, Maria V. Sergeeva et al. · 2021 · EClinicalMedicine
Relative Burdens of the COVID-19, Malaria, Tuberculosis, and HIV/AIDS Epidemics in Sub-Saharan Africa
David Bell, Kristian Schultz Hansen · 2021 · American Journal of Tropical Medicine and Hygiene
The way of SARS-CoV-2 vaccine development: success and challenges
Yetian Dong, Tong Dai, Bin Wang, Lei Zhang, Linghui Zeng, Jun Huang, Haiyan Yan, Long Zhang, Fangfang Zhou · 2021 · Signal Transduction and Targeted Therapy
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
Tawanda Chivese, Joshua T. Matizanadzo, Omran A. H. Musa, George Hindy, Luis Furuya‐Kanamori, Nazmul Islam, Rafal Al-Shebly, Rana Shalaby, Mohammad Habibullah, Talal A. Al-Marwani et al. · 2022 · Pathogens and Global Health
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie · 2023 · Frontiers in Immunology
SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron’s impact in South African population cohorts
Sun, Kaiyuan, Tempia, Stefano, Kleynhans, Jackie, von Gottberg, Anne, McMorrow, Meredith L., Wolter, Nicole, Bhiman, Jinal N., Moyes, Jocelyn, du Plessis, Mignon, Carrim, Maimuna et al. · 2022 · Science Translational Medicine
Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection
Hao Wang, Yu Lai Yuan, Mingzhong Xiao, Li Chen, Youyun Zhao, Haiwei Zhang, Pinpin Long, Yana Zhou, Xi Zhu Xu, Yanshou Lei et al. · 2021 · Cellular and Molecular Immunology
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
A. Markmann, Natasa Giallourou, D. Bhowmik, Y. Hou, A. Lerner, David R. Martinez, L. Premkumar, H. Root, D. van Duin, S. Napravnik et al. · 2021 · Msphere
Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study
Ting Shi, Jiafeng Pan, Eleftheria Vasileiou, Chris Robertson, Aziz Sheikh · 2022 · The Lancet Respiratory Medicine
High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform
Peter M. Bruno, Richard T. Timms, Nouran S. Abdelfattah, Yumei Leng, Felipe Lelis, Duane R. Wesemann, Xu G. Yu, Stephen Joseph Elledge · 2023 · Nature Biotechnology
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19
Reza Zonozi, Lucy C. Walters, Aaron Shulkin, Vivek Naranbhai, Pravarut Nithagon, Gabriel Sauvage, Clarety Kaeske, Katherine M. Cosgrove, Anusha Nathan, Rhoda Tano-Menka et al. · 2023 · Science Translational Medicine
Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals
Mitnala Sasikala, Shashidhar Jaggaiahgari, Deepika Gujjarlapudi, Vishnubhotla Venkata Ravikanth, Vemula Venkata Krishna, Sadhana Yelamanchili, Pragathi Kottapalli, D. Nageshwar Reddy · 2021 · International Journal of Infectious Diseases
T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
Stepan A. Nersisyan, Anton Zhiyanov, M. Yu. Shkurnikov, Alexander Tonevitsky · 2021 · Nucleic Acids Research
SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications
Gianluca Russo, Quirino Lai, Luca Poli, Maria Paola Perrone, Aurelia Gaeta, Massimo Rossi, Claudio Maria Mastroianni, Manuela Garofalo, R. Pretagostini · 2021 · Clinical Transplantation
SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection
Yan Zhan, Yufang Zhu, Shanshan Wang, Shijun Jia, Yunling Gao, Yingying Lü, Cai-Li Zhou, Ran Liang, Dingwen Sun, Xiaobo Wang et al. · 2021 · Signal Transduction and Targeted Therapy
Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days
Qiu‐Yan Xu, Jian-Hang Xue, Yao Xiao, Zhi-Juan Jia, Mengjuan Wu, Yan‐Yun Liu, Wei-Li Li, Xianming Liang, Tian‐Ci Yang · 2021 · Frontiers in Immunology
Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review
Taylor J. Louis, Ahmad Qasem, Latifa S. Abdelli, Saleh A. Naser · 2022 · Microorganisms
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson · 2022 · Immunological Reviews
Regulatory circuits of mitophagy restrict distinct modes of cell death during memory CD8 + T cell formation
Fabien Franco, Alessio Bevilacqua, Ruey-Mei Wu, Kung‐Chi Kao, Chun‐Pu Lin, Lorène Rousseau, Fu‐Ti Peng, Yu‐Ming Chuang, Jhan-Jie Peng, Jaeoh Park et al. · 2023 · Science Immunology
Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
André E. Nel, Jeff F. Miller · 2021 · ACS Nano
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
Hassan Alkharaan, Shaghayegh Bayati, Cecilia Hellström, Soo Aleman, Annika Olsson, Karin Lindahl, Gordana Bogdanović, Katie Healy, Georgios Tsilingaridis, Patricia Palma et al. · 2021 · The Journal of Infectious Diseases
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Carolina Garrido, Jillian H. Hurst, Cynthia G. Lorang, Jhoanna N. Aquino, Javier Rodriguez, Trevor S. Pfeiffer, Tulika Singh, Eleanor C. Semmes, Debra J. Lugo, Alexandre Tellechea Rotta et al. · 2021 · JCI Insight
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
Richard A. Urbanowicz, Theocharis Tsoleridis, Hannah J. Jackson, Lola Cusin, Joshua D. Duncan, Joseph G. Chappell, Alexander W. Tarr, Jessica Nightingale, Alan R. Norrish, Adeel Ikram et al. · 2021 · Science Translational Medicine
Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
Rachel M. Burckhardt, John J. Dennehy, Leo L. M. Poon, Linda J. Saif, Lynn W. Enquist · 2021 · Journal of Virology
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design
Heinrich Scheiblauer, Claudius Micha Nübling, Timo Wolf, Yascha Khodamoradi, Carla Bellinghausen, Michael Sonntagbauer, Katharina Esser‐Nobis, Angela Filomena, Vera Mahler, Thorsten J. Maier et al. · 2021 · Journal of Clinical Virology
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
Nicholas Kim Huat Khoo, Joey Ming Er Lim, Upkar S. Gill, Ruklanthi de Alwis, Nicole Tan, Justin Zhen Nan Toh, Jane E. Abbott, Carla Usai, Eng Eong Ooi, Jenny Guek Hong Low et al. · 2022 · Med
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck‐Jones, Sindhu Vangeti, Eric Åhlberg, Lida Azizmohammadi, Anna Warnqvist, Ryan Falck‐Jones et al. · 2021 · JCI Insight
SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults
Sophia Björkander, Likun Du, Fanglei Zuo, Sandra Ekström, Yating Wang, Hui Wan, Natalia Sherina, Lisanne Schoutens, Juni Andréll, Niklas Andersson et al. · 2021 · Journal of Allergy and Clinical Immunology
Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status
Esther Dawen Yu, Eric W. Wang, Emily Garrigan, Benjamin Goodwin, Aaron Sutherland, Alison Tarke, James Chang, Rosa Isela Gálvez, José Mateus, Sydney I. Ramirez et al. · 2022 · Cell Host & Microbe
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim B. Boonyaratanakornkit, Anna Wald, Stacy Selke, Mark H. Wener, Chihiro Morishima, Alexander L. Greninger et al. · 2022 · JCI Insight
Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Sudeb C. Dalai, Jennifer N. Dines, Thomas M. Snyder, Rachel Gittelman, Tera Newman-Eerkes, Pashmi Vaney, Sally Howard, Kipp Akers, Lynell R. Skewis, Anthony J. Monteforte et al. · 2022 · Clinical Infectious Diseases
Putative Role of Vitamin D for COVID-19 Vaccination
Sheng-Kang Chiu, Kuo‐Wang Tsai, Chia‐Chao Wu, Cai‐Mei Zheng, Chung‐Hsiang Yang, Wan‐Chung Hu, Yi‐Chou Hou, Kuo‐Cheng Lu, You‐Chen Chao · 2021 · International Journal of Molecular Sciences
IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers
Giulia Brisotto, Elena Muraro, Marcella Montico, Chiara Corso, Chiara Evangelista, Mariateresa Casarotto, Cristina Caffau, Roberto Vettori, Maria Rita Cozzi, Stefania Zanussi et al. · 2021 · Clinica Chimica Acta